Product
LY3316531
Aliases
LY3316531 - IV, LY3316531 - SC
1 clinical trial
1 indication
Indication
PsoriasisClinical trial
A Phase 1 Randomized, Placebo-Controlled Study of LY3316531 in Healthy Subjects and an Open-Label, Single-Dose Study in Patients With PsoriasisStatus: Completed, Estimated PCD: 2018-12-24